Event Details

Characterization of Nanomaterials for Medical and Health Applications

A Workshop jointly sponsored by ASTM, NCI, NIST and FDA

Thursday, May 19, 2005
Hilton Reno Resort
Reno, Nevada

ASTM, NCI, NIST and U.S. FDA co-sponsored this workshop to facilitate the development and use of nanomaterials for medical and health applications. The workshop provided a forum for the development of standards for the characterization of nanomaterials and its behavior in biological systems. This standards development effort may also lay the groundwork for ascertaining and monitoring the environmental, health, and safety ramifications of nanotechnology for other applications.

 View meeting report

AGENDA
Morning Session
8:00 am – 8:20 am	Registration and Welcome Scott McNeil, Ph.D., NCI-Frederick
8:20 am – 8:40 am	ASTM Standardization Efforts in Nanotechnology Pat Picariello, ASTM International
8:40 am – 9:10 am	Keynote Address: Galvanizing the New Generation of Nano-Based Products for Cancer Greg Downing, D.O., Ph.D., NCI-Frederick
9:10 am – 9:50 am	Dendrimeric Devices James Baker Jr., M.D., University of Michigan
10:05 am – 10:25 am	NIST Nano-Bio Activities Eric Steele, National Institute of Standards and Technology
10:25 am – 11:00 am	Using Standards to Enable Product Approval Don Marlowe, Food and Drug Administration
11:00 am – 11:40 am	Nanoparticles and Targeted Drug Delivery using Ultrasound Kenneth Watkin, Ph.D., Ultra-Imaging, LLC
Afternoon Session
1:00 pm – 1:45 pm	Characterization of Drug Nanosuspension Barrett Rabinow, Ph.D., Baxter Healthcare Corp
1:45 pm – 2:30 pm	Liposomal Strategies Greg Lanza, M.D., Ph.D., Washington University Medical School
2:30 pm – 3:15 pm	Silicon-based Strategies Mauro Ferrari, Ph.D., Ohio State University
3:30 pm – 4:40 pm	NCL’s Efforts in Standardization and Characterization Scott McNeil, Ph.D., Anil Patri, Ph.D., Steve Stern, Ph.D., NCI-Frederick